Comparison of hematological toxicities between innovator and generic cisplatin formulations in cervical cancer patients treated with concurrent chemoradiotherapy

To compare the incidence and degree of hematological toxicity between innovator and generic cisplatin formulations, decreases in white blood cell (WBC) count (leukopenia) and platelet counts (thrombocytopenia) were retrospectively examined, using the Common Toxicity Criteria for Adverse Events ver....

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Oike, Takahiro, Ohno, Tatsuya, Noda, Shin-ei, Sato, Hiro, Tamaki, Tomoaki, Kiyohara, Hiroki, Ando, Ken, Nakano, Takashi
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2013
Konular:
Oncology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3650746/
https://ncbi.nlm.nih.gov/pubmed/23242248
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jrr/rrs121
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller